News
Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump ...
By Ryan Hogg, CNN London (CNN) — Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after ...
Lilly said Thursday that it has an agreement with the U.K. government to raise the list price of Mounjaro for patients who pay for it out-of-pocket.
Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White House push to get drugmakers to raise medicine prices in Europe to ...
As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly seems willing to play ball. | Eli Lilly said it has "intensified efforts ...
Hosted on MSN16d
1 Reason to Buy Eli Lilly (LLY) Stock - MSN
Shares of Eli Lilly(NYSE: LLY) have made some investors much richer. Over the last decade, for example, Eli Lilly stock averaged annual gains of 25.1%, enough to turn a $10,000 investment into a ...
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients abroad remains unclear.
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its most profitable drugs, including the high-demand GLP-1 medications ...
Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading to millions in improper Medicaid claims.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results